SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis

Overview of attention for article published in Molecular Cancer, March 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 62 followers.

SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis https://t.co/xTBs2HIiUP

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.